After 30 years, scientists finally have a drug for a deadly brain disease
The FDA has approved the first drug that directly targets Alexander disease, a devastating neurological disorder affecting fewer than one in a million people. Developed through decades of research, Zanvastro showed promising results in clinical trials, stabilizing motor function
The FDA has approved the first drug that directly targets Alexander disease, a devastating neurological disorder affecting fewer than one in a million people. Developed through decades of research, Zanvastro showed promising results in clinical trials, stabilizing motor function This story matters for Health & Wellness readers tracking gym. Reported by sciencedaily.com. Read the full original at the source link below.
Originally reported by sciencedaily.com. GymNews.com curates and briefs the health & wellness stories that matter. Our editorial policy →
Get the daily gym signal